Champions Oncology, Inc.CSBRNASDAQ
Loading
Year-over-year revenue growth rate
5Y CAGR
+8.1%/yr
Long-term compound
Percentile
P69
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q1 2026 | 10.14% |
| Q4 2025 | 7.43% |
| Q3 2025 | 13.27% |
| Q2 2025 | -27.49% |
| Q1 2025 | 26.32% |
| Q4 2024 | -4.07% |
| Q3 2024 | 0.43% |
| Q2 2024 | 16.49% |
| Q1 2024 | 3.85% |
| Q4 2023 | -7.87% |
| Q3 2023 | -3.90% |
| Q2 2023 | 2.33% |
| Q1 2023 | -10.56% |
| Q4 2022 | 3.90% |
| Q3 2022 | 6.74% |
| Q2 2022 | -2.40% |
| Q1 2022 | 11.94% |
| Q4 2021 | 4.74% |
| Q3 2021 | 6.51% |
| Q2 2021 | -2.28% |
| Q1 2021 | 6.87% |
| Q4 2020 | 5.97% |
| Q3 2020 | 9.11% |
| Q2 2020 | -2.91% |
| Q1 2020 | 18.19% |
| Q4 2019 | 13.18% |
| Q3 2019 | -12.71% |
| Q2 2019 | 20.03% |
| Q1 2019 | -3.93% |
| Q4 2018 | 7.52% |
| Q3 2018 | 26.47% |
| Q2 2018 | -3.15% |
| Q1 2018 | -2.33% |
| Q4 2017 | 3.38% |
| Q3 2017 | 35.30% |
| Q2 2017 | 4.35% |
| Q1 2017 | -20.01% |
| Q4 2016 | 21.44% |
| Q3 2016 | 29.36% |
| Q2 2016 | 11.17% |